Cochlear sensory hair cells (HCs) are crucial for hearing as mechanoreceptors of the auditory systems. Clarification of transcriptional regulation for the cochlear sensory HC development is crucial for the improvement of cell replacement therapies for hearing loss. Transcription factor Atoh1 is the key player during HC development and regeneration. In this review, we will focus on Atoh1 and its related signaling pathways (Notch, fibroblast growth factor, and Wnt/-catenin signaling) involved in the development of cochlear sensory HCs. We will also discuss the potential applicability of these signals for the induction of HC regeneration.
INTRODUCTION
Hearing loss represents a major health problem. It affects over 5% of the world's population. The World Health Organization (WHO) has estimated that 360 million people in the world are suffering from hearing impairment (WHO, 2013) . As people's life spans are extended compared to those in the past, the incidence of sensorineural hearing loss (SNHL) has also increased. 1 SNHL can arise from several causes including aging, noise trauma, ototoxic drugs, genetic disorders, and infections. This disability can influence an individual's social, functional, and psychological well-being. It can cause isolation, dependence, frustration, and communication problems.
2 SNHL is commonly caused by cochlear sensory hair cell (HC) defects, consequently leading to auditory spiral ganglion neuron loss. 3 In mammals, hearing impairment due to sensory HC loss in the cochlea is irreversible because lost cochlear hair cells cannot be spontaneously regenerated. 4, 5 Current treatments for SNHL such as hearing aids, middle ear implants, and cochlear implants do provide benefits to patients. However, their outcomes are diverse. 6, 7 Recently, there has been a strong research focus on alternative treatments for SNHL. Understanding the transcriptional regulation mechanism involved in sensory HCs development and specification has led to a new opening of strategies for treating SNHL by cell or gene therapies. 8 Here, we will review a key transcriptional factor (Atoh1) and its related signaling pathway (Notch, fibroblast growth factor, and Wnt/β-catenin signaling) involved in the development of cochlear sensory HCs. We will also discuss the potential applicability of these signals for the induction of HC regeneration.
THE SENSORY EPITHELIUM OF THE COCHLEA
In mammals, hearing and balance are regulated by sensory HCs located in the cochlear duct and vestibular organs of the inner ear. Cochlear sensory hair cells are mechanosensory receptors. They convert sound into electrical signals. 9 There are approximately 16,000 sensory HCs located in the organ of Corti. The inner HCs are arranged in a single row and outer HCs are arranged in three rows (Fig. 1) . Inner HCs excite type I spiral ganglion neurons. A single inner HC makes synaptic connection with numerous type I afferent nerve fibers. Outer HCs enhance the responsiveness of the sensory epithelium to specific frequencies and detect low intensity sound. 10 They are innervated by type II afferent nerve fibers. A single afferent nerve fiber can innervate many outer HCs. 11 These complex cochlear sensory systems are formed via delicate cell fate decision and differentiation 
FIG. 2.
Atoh1 gene expression during inner ear development. Atoh1 is expressed in the proneuronal cells at E14.5 (A, B) and expressed in sensory hair cells in the cochlea at E16.5 and P1 (C-F). In adult mammals, hair cells are located in the organ of Corti (G, H&E staining) and have stereocillia (H, scanning electro-microscopic image). OHC: outer hair cell, IHC: inner hair cell.
processes tightly controlled by a combination of numerous intrinsic and extrinsic signaling pathways. 12 The specification of prosensory regions in the otocyst is the initial step during the development of sensory epithelia in the inner ear. During the development of the prosensory region, numerous intrinsic and extrinsic signaling pathways are required. These singling pathways are highly ordered to generate proper functioning HCs. 13, 14 Numerous genes are related to sensory inner ear HC specification/differentiation, such as Atonal homolog 1 (Atoh1; Math1), growth factor independent 1 (Gfi1), Pou4f3, miRNA-183, 15 and connexin26 gene (GJB2). 16, 17 Among these potential genes for HC specification and regeneration, Atoh1 is a 'key gene' in HC development because its activity at different developmental periods can sufficiently induce cochlear HC differentiation.
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THE ROLE OF ATOH1 IN INNER EAR HC DEVELOPMENT
Atoh1 is a proneural basic helix-loop-helix (bHLH) transcription factor. It is the first gene discovered in inner ear development. 18 Several studies have revealed that Atoh1 regulates not only the development of various kinds of neural cells such as the spinal cord, 19 inner ear HCs, [20] [21] [22] cerebellar neurons, 23 and proprioceptive system neurons, 24, 25 but also several types of nonneural cells such as intestinal secretory cells. 26, 27 During inner ear development, Atoh1 has a key role in HC differentiation. Atoh1 expression represents the prosensory region in the development of cochlea. Atoh1 positive cells can generate sensory HCs. 28 In mice, the organ of Corti develops from a postmitotic pros-ensory domain in the cochlear duct formed between embryonic days (E) 12.5 and E14. 29, 30 Atoh1 is first expressed in the base of the cochlea at E 12.5. It is up-regulated in primitive HCs in the mid-basal region between E13.5 and E 14.5 in mice. During inner ear development in mice, it spreads apically along the prosensory domain until modelling of organ of Corti is complete around E17.5. 31 In addition, Atoh1 is essential for HC survival shortly after differentiation between E15.5 to E17.5. It is required for HC maturation, including the formation of stereociliary bundles (Fig. 2) . 32, 33 On the other hand, Atoh1 ectopic expression could generate diverse phenotypes of cochlea. In the embryonic stage, overexpressed Atoh1 can form supernumerary cochlear sensory HCs. 34 In neonatal mice, Atoh1 overexpression can form HCs from supporting cells. [35] [36] [37] [38] [39] [40] However, such ectopic HC generation ability of Atoh1 is significantly reduced in mature or undamaged cochlea. 36, 41 Many molecules including Pou4f3, Gfi1, Myosin 7a were suggested to be down-stream genes of Atoh1 by transcriptome analysis. However, the concise role of these genes in the context of Atoh1 work is yet to be defined.
Because Atoh1 has a crucial role in the generation of cochlear HCs, many cochlear HC regeneration studies have focused on Atoh1 5, 42, 43 However, these studies have limitations in that the efficacy of Atoh1 might be variable and regenerated HC did not function properly. 42, 43 Although Atoh1 itself is insufficient to regenerate functional HCs, these studies have served as a foundation for other studies to determine candidate signaling pathways that can control Atoh1 expression and HC differentiation. Those signaling pathways are discussed below.
ATOH1 RELATED SIGNALING PATHWAYS INVOLVED IN HC DEVELOPMENT AND REGENERATION
Notch signaling (Fig. 3)
In many tissues, notch signaling is one of the most important pathways that regulates cell differentiation, proliferation, and cell death by lateral inhibition. Notch receptors and ligands Delta and Serrate (Jagged in mammals) are trans-membrane receptor proteins highly expressed in many tissues. 44 The Notch trans-membrane receptor molecule is activated via direct interaction with an adjacent cell surface trans-membrane ligand. This interaction promotes cleavage of Notch receptors to release notch intracellular domain (NICD). The released NICD is translocated to the nucleus to bind to RBP-JK family and act as a transcriptional coactivator. This transcriptional coactivator activates the expression of target genes such as Hes1, leading to repression of downstream target genes.
During the differentiation of HCs and supporting cells, Notch signaling plays an important role by lateral inhibition. In mammals, there are four notch receptors (Notch 1-4) and five canonical notch ligands (Delta-like 1, 3, 4 and Jagged 1, 2). 45 Many studies have demonstrated that Notch ligands are expressed in developing HCs and that Notch receptors are expressed more broadly than Notch ligands. [46] [47] [48] [49] Notch signaling is activated upon cell-to-cell contact, which is an initial step of lateral inhibition. Notch signaling produces inhibitory bHLH proteins (HES1 and HES5) that block the effect of Atoh1, leading to inhibition of the HC fate. These inhibited cells subsequently differentiate into supporting cells. Individual deletion of notch ligand Delta-like (Dl1) or Jagged 2 results in a significant increase in sensory HCs. 49, 50 Downstream molecules of Notch signaling during hair cell differentiation are products of Hairy and Enhancer-of-Split genes in Drosophila. In vertebrates, bHLH transcription factor family genes, Hes/Hey are homologs of Hairy and Enhancer-of-split genes. 51 Several studies have revealed that Hes/Hey family members are expressed in supporting cells and that Hes/Hey deletions promote hair cell differentiation. [52] [53] [54] [55] Interestingly, Hes/Hey family members are individually expressed in different part of the cochlea. They may control different supporting cell populations. For example, overproduction of inner HCs has occurred via Hes1 inactivation whereas overproduction of outer HCs can be caused by Hes5 deletion. 53 Several studies have also revealed that many Hes/Hey family members and other downstream factors of Notch are effectors in lateral inhibition. 55, 56 Numerous studies have shown that Notch inhibition can affect hair cell regeneration. The most commonly studied drugs used to block Notch signaling are -secretase inhibitors. 57, 58 These studies have demonstrated that -secretase inhibitors can increase the number of regenerated HCs in damaged zebrafish lateral line 57 or damaged chick cochlea. 58 In addition, Notch inhibition could change supporting cells to new nascent HCs in undamaged neonatal mouse cochlea. 59, 60 In mammalian vestibular organs, Notch signaling inhibition could significantly induce more supporting cells to activate Atoh1 gene expression and change supporting cells to mature myosin VIIa-expressing HCs after vestibular HCs damage. [61] [62] [63] However, in damaged, mature mammalian cochlea, pharmacological trials using Notch signaling inhibitors have been unsatisfactory. 64, 65 Taken together, these results imply that Notch inhibition is a promising strategy for HC regeneration in damaged cochlea.
Fibroblast growth factor (FGF)
Currently, 22 FGF ligand genes and 4 FGF receptor genes have been identified in mammals. They play important roles during the development of CNS 66 and multiple sensory organs. 67, 68 During inner ear development, FGF signaling regulates otic placode induction 69 and early otocyst formation. 68 In the later stages during inner ear development, FGF family also regulates the formation of auditory HCs. In particular, FGF20 signals through FGF receptor 1 to promote early HC specification in mice developing cochlea and treatment with FGF signaling inhibitors decreases Atoh1 expression at E14. 70, 71 After initiating HC differentiation, interaction between FGF8 in nascent in- ner HCs and FGF receptor 3 in supporting cells is essential for the development of pillar cells (which are found in the organ of Corti and act as supporting cells for HCs) and inhibition of such interaction leads to the formation of excess ectopic HCs and a decrease of supporting cells. [72] [73] [74] [75] Interestingly, Notch inhibition could not convert pillar cells into HCs because they are specified by notch independent Hey2 expression which is activated by FGF signaling, unlike other supporting cell subtypes. Therefore, FGF receptor blockage allows pillar cells to be more responsive to Notch inhibition. 76 Furthermore, FGF signaling pathway is related to Atoh1 during inner ear development. 77 For example, in the presence of FGF2, several neurotropic factors (NGF, BDNF and NT-3) can significantly increase Atoh1 expressions. 78 In zebrafish, FGF3 and FGF8 signals are upstream activators of Atoh1 genes during the development of preotic placode and otic vesicle. 79 FGF20 also indirectly activates Atoh1 expression through FGF receptor 1 and activates Ets-domain transcription factors PEA3 and ERM, which then can activate Atoh1 expression. 70 Collectively, these studies reveal that FGF signaling could control the specification of prosensory cells and subsequent differentiation into HCs and supporting cells during inner ear development. In addition, the FGF signaling pathway interacts with the Notch signaling pathway dur- ing cochlear development and controls Atoh1 expression.
Wnt/-catenin signaling
The Wnt (Wingless-related integration site) signaling pathway is composed of a set of secreted factors (Wnts) and Frizzled receptors. There are 19 different Wnt genes in murine and human genomes. 80 The Wnt signaling pathway is a hallmark of many embryonic stages with multiple different roles at each time point. In the inner ear, it participates in otic specification, vestibular organ formation, and development of the cochlea.
In cochlear development, active canonical Wnt signaling is mediated by -catenin translocated into the nucleus. It can bind the T cell factor/lymphoid enhancer-binding factor (TCF/LEF) family of transcription factors to initiate transcription (Fig. 4) . This canonical Wnt/-catenin signaling is known to control both development and homeostasis in many tissues. 81 Canonical Wnt/-catenin signaling has been proposed to be upstream of both Atoh1 and Sox2 during cochlear HC and retina cell development. 82, 83 During otic placode development, a gradient of Wnt signaling determines the size of otic placode. The Wnt pathway also interacts with the notch pathway. 84 Recently, it has been reported that canonical Wnt/-catenin signaling is upregulated in cochlear prosensory cells and that inhibition of Wnt/-catenin signaling blocks the development of prosensory cells during early cochlear development. 85 Furthermore, Wnt signaling activator LiCl can expand Sox2-expressing prosensory cells and increase sensory HC number. Another experiment using transgenic mice revealed that -catenin deletion at different developmental stages resulted in different phenotypes. When -catenin is deleted during the prosensory period, differentiation of both HCs and pillar cells was prevented. However, when -catenin was deleted after sensory HC differentiation in the cochlea, it failed to affect HC maturation. 86 These results suggest that Wnt/-catenin signaling is indispensable for prosensory cell proliferation and sensory HC differentiation but not for sensory HC maturation. In addition, Wnt/-catenin activation can drive G-protein-coupled receptor 5 (Lgr5)-expressing cells to act as HC progenitors in neonatal cochlea. 87, 88 Although many studies have determined the roles of canonical Wnt signaling during mammalian cochlea development, only a few studies have begun to elucidate its potential for regenerating HCs in damaged cochlea. As previously described, the Lgr5 positive cell is one candidate cell for HC regeneration in damaged cochlea. It requires a Wnt signaling agonist to acquire proliferative behavior. Over-expression of -catenin can also induce ectopic HC formation in the cochlea. 85, 86 HC damage can stimulate Lgr5 positive supporting cells to proliferate and regenerate HCs or directly transdifferentiate into HCs. 89 During HC regeneration, Wnt/-catenin signaling can promote HC regeneration by increasing cell proliferation and Atoh1 expression (Fig. 5) . 87, 88, 90 More recently, Kuo et al. have reported that -catenin and Atoh1 have synergistic effects on both cochlear HC generation and survival in neonatal mice. 91 However, there have been no mitogenic or prosensory effects after damage in the supporting cells of adult mouse cochlea. 87 In summary, these studies demonstrate that activation of Wnt/-catenin signaling can force neonatal cochlear supporting cell proliferation and lead to HC regeneration. Therefore, it is reasonable to establish a regenerative strategy by initial Wnt activation to enhance supporting cell proliferation, followed by prosensory regenerating signals such as notch inhibition and forced Atoh1 expression to induce HC differentiation. 92 Because the interaction between Notch and Wnt pathways in inner ear is limited, 59 more studies are required to further reveal the mechanisms involved in cochlear HC regeneration. 
Transcriptional profiling of mESCs after forced Atoh1
expression Several studies have attempted to find down-stream molecules of Atoh1. We also conducted this work using Atoh1 overexpressing (doxycycline inducible system) embryonic stem cells (ESCs) as follows. ESCs were spontaneously differentiated for 2 days followed by Atoh1 over-expression for another 2 days. Cells were collected and tran-scriptome changes were evaluated by RNA-sequencing. Gene ontology analysis showed several up-regulated pathways such as Notch signaling, neuron migration, glutamate receptor, action potential regulation, and neurotransmitter regulation (unpublished data). On the other hand, BMP signaling, Wnt signaling, and mesoderm formation related genes were down-regulated by Atoh1 overexpression. In similar contexts with previous transcriptome studies, 93, 94 these pathways might play a role in the hair cell development.
SUMMARY
Numerous genes are related to sensory inner ear HC specification and differentiation. Among these genes, Atoh1 is a 'key gene' in HC development. At the otic placode stage, FGF signaling regulates its induction as well as early otocyst formation. Also, FGF20 signal promotes early HC specification via increasing Atoh1 expression at E12-E14. Wnt/-catenin signaling has been proposed to be upstream of Atoh1 during cochlear development. It can increase mitotic HC regeneration by promoting cell proliferation and increasing Atoh1 expression during HC regeneration. During differentiation of HCs and supporting cells, Notch signaling plays an important role mainly via lateral inhibition. In addition, Notch inhibition can induce HC regeneration. Moreover, Notch inhibition can significantly increase Atoh1 expression (Fig. 6 ). Taken together, these results imply that Atoh1 and its related signaling pathway genes might offer promising approaches for HC regeneration in damaged cochlea.
